1. Home
  2. TRT vs SONN Comparison

TRT vs SONN Comparison

Compare TRT & SONN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRT
  • SONN
  • Stock Information
  • Founded
  • TRT 1958
  • SONN N/A
  • Country
  • TRT United States
  • SONN United States
  • Employees
  • TRT N/A
  • SONN N/A
  • Industry
  • TRT Industrial Machinery/Components
  • SONN Biotechnology: Pharmaceutical Preparations
  • Sector
  • TRT Technology
  • SONN Health Care
  • Exchange
  • TRT Nasdaq
  • SONN Nasdaq
  • Market Cap
  • TRT 35.1M
  • SONN 32.4M
  • IPO Year
  • TRT N/A
  • SONN N/A
  • Fundamental
  • Price
  • TRT $8.20
  • SONN $4.37
  • Analyst Decision
  • TRT
  • SONN Strong Buy
  • Analyst Count
  • TRT 0
  • SONN 1
  • Target Price
  • TRT N/A
  • SONN $20.00
  • AVG Volume (30 Days)
  • TRT 17.4K
  • SONN 770.6K
  • Earning Date
  • TRT 11-14-2025
  • SONN 12-16-2025
  • Dividend Yield
  • TRT N/A
  • SONN N/A
  • EPS Growth
  • TRT N/A
  • SONN N/A
  • EPS
  • TRT 0.06
  • SONN N/A
  • Revenue
  • TRT $42,188,000.00
  • SONN $1,000,000.00
  • Revenue This Year
  • TRT N/A
  • SONN $5,376.22
  • Revenue Next Year
  • TRT N/A
  • SONN N/A
  • P/E Ratio
  • TRT $120.09
  • SONN N/A
  • Revenue Growth
  • TRT 0.10
  • SONN 1689.52
  • 52 Week Low
  • TRT $4.62
  • SONN $1.08
  • 52 Week High
  • TRT $8.48
  • SONN $19.30
  • Technical
  • Relative Strength Index (RSI)
  • TRT 67.83
  • SONN 46.70
  • Support Level
  • TRT $6.50
  • SONN $4.05
  • Resistance Level
  • TRT $8.07
  • SONN $5.14
  • Average True Range (ATR)
  • TRT 0.45
  • SONN 0.97
  • MACD
  • TRT 0.10
  • SONN -0.01
  • Stochastic Oscillator
  • TRT 86.00
  • SONN 43.46

About TRT Trio-Tech International

Trio-Tech International operates in the semiconductor industry, providing manufacturing, testing, and distribution services for semiconductor test equipment and electronic components. It has two main segments: Semiconductor Back-end Solutions (SBS) and Industrial Electronics (IE). The SBS segment, which generates the majority of the Company's revenue, focuses on manufacturing equipment for semiconductor back-end processes, offering testing services, and distributing burn-in test related equipment. The IE segment manufactures equipment for other industries and distributes electronic products outside the semiconductor sector. The Company operates in the United States, Singapore, Malaysia, Thailand, and China, serving customers across multiple regions.

About SONN Sonnet BioTherapeutics Holdings Inc.

Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company. The Company views its operations and manages its business in one segment. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.

Share on Social Networks: